RADICAL CYSTECTOMY FOR HISTORICAL AND PATHOLOGIC-T1, N0, M0 (STAGE-A) TRANSITIONAL CELL-CANCER - NEED FOR ADJUVANT SYSTEMIC CHEMOTHERAPY

被引：24
|
作者：
SIREF, LE [1 ]
ZINCKE, H [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,DEPT UROL,ROCHESTER,MN 55905
来源：
UROLOGY | 1988年 / 31卷 / 04期
关键词：
D O I：
10.1016/0090-4295(88)90087-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：309 / 311
页数：3
相关论文
共 50 条
  • [11] Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: Therapeutic results and voice preservation
    Spector, JG
    Sessions, DG
    Chao, KSC
    Haughey, BH
    Hanson, JM
    Simpson, JR
    Perez, CA
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1999, 21 (08): : 707 - 717
  • [12] IMPACT OF ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH T1N1M0/T2N0M0 GASTRIC CANCER
    Chen, Yi Fu
    Le, Puo-Hsien
    Chen, Tsung Hsing
    Kuo, Chia Jung
    Wang, Shang Yu
    Chou, Wen Chi
    Yeh, Ta Sen
    Hsu, Jun Te
    GASTROENTEROLOGY, 2024, 166 (05) : S669 - S669
  • [13] Evaluation of Clinical Prognostic Factors in T1 N0 M0 Head and Neck Basal Cell Carcinoma
    Morselli, Paolo
    Zollino, Ilaria
    Pinto, Valentina
    Brunelli, Giorgio
    Carinci, Francesco
    JOURNAL OF CRANIOFACIAL SURGERY, 2009, 20 (01) : 98 - 100
  • [14] Radikale Zystektomie vs. Radiochemotherapie zur Behandlung des Blasenkarzinoms im Stadium T2–4a N0 M0Radical cystectomy vs. chemoradiation for the treatment of T2–4a N0 M0 bladder cancer
    Gunther Klautke
    Strahlentherapie und Onkologie, 2016, 192 (11) : 823 - 824
  • [15] Factors Affecting Outcomes of Limited-Stage I, IIA (T1-T2, N0, M0) Small Cell Lung Cancer: An Analysis of the National Cancer Database
    Abdullah, H. M.
    Das, A. C.
    Abughanimeh, O. K.
    Muir, K. -L.
    Sharma, B. B.
    Marr, A. S.
    Smith, L. M.
    Ganti, A. K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S677 - S677
  • [16] Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer
    Kodama, Ken
    Higashiyama, Masahiko
    Okami, Jiro
    Tokunaga, Toshiteru
    Imamura, Fumio
    Nakayama, Tomio
    Inoue, Atsuo
    Kuriyama, Keiko
    ANNALS OF THORACIC SURGERY, 2016, 101 (02): : 504 - 511
  • [17] Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer
    Jeon, Chul-Hyo
    Kim, Min Ki
    Lee, In Kyu
    ANNALS OF COLOPROCTOLOGY, 2019, 35 (05) : 254 - 261
  • [18] Should patients with a complete response (CR) to chemotherapy for stage T4b, M0, bladder cancer be advised immediate radical cystectomy?
    Geertsen, P
    Steven, K
    Poulsen, AL
    Sengelov, L
    JOURNAL OF UROLOGY, 2002, 167 (04): : 285 - 285
  • [19] THE ROLE OF ADJUVANT THERAPY AFTER RESECTION OF T1 N1 M0 AND T2 N1 M0 NON-SMALL CELL LUNG-CANCER
    FERGUSON, MK
    LITTLE, AG
    GOLOMB, HM
    HOFFMAN, PC
    DEMEESTER, TR
    BEVERIDGE, R
    SKINNER, DB
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 91 (03): : 344 - 349
  • [20] Genitourinary group phase II study of chemotherapy in stage T3-4 N0-X M0 transitional cell cancer of the bladder: Prognostic factor analysis
    Splinter, TAW
    PavoneMacaluso, M
    Jacqmin, D
    Roberts, JT
    Carpentier, P
    dePauw, M
    Sahmoud, T
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (07) : 1129 - 1134
12345